Literature DB >> 6540134

New possibilities of cytostatic drug testing on patient tumor cells by flow cytometry.

G Valet, H H Warnecke, H Kahle.   

Abstract

A new assay for cytostatic drug testing is described which can be automated. Pleural effusions and ascites are cultured as such for one week. Cells of solid tumors are cultured in the patients own serum for the same time. The cells are then stained with the esterase and intracellular pH-indicator dye 1,4-diacetoxy-2,3-dicyano-benzene (ADB) to label vital cells. They are simultaneously stained with propidium iodide (PI) as an indicator for dead cells. Monosized fluorescent latex particles are added as concentration, volume and fluorescence standard. Inflammatory cells can be distinguished in the assay from tumor cells because of their small cell volume. The number of dead and surviving cells is counted by the flow cytometer and a therapeutic index is calculated as ratio between the surviving inflammatory to surviving tumor cells. An important feature of the assay is that the DNA-distribution of the dead cells (e.g. aneuploidy) as well as the functional state of the surviving tumor cells and inflammatory cells can be judged from intracellular esterase activity and intracellular pH.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6540134     DOI: 10.1007/bf00320382

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  9 in total

1.  Direct cloning of human ovarian carcinoma cells in agar.

Authors:  A W Hamburger; S E Salmon; M B Kim; J M Trent; B J Soehnlen; D S Alberts; H J Schmidt
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

2.  Fluvo-metricell, a combined cell volume and cell fluorescence analyzer.

Authors:  V Kachel; E Glossner; E Kordwig; G Ruhenstroth-Bauer
Journal:  J Histochem Cytochem       Date:  1977-07       Impact factor: 2.479

3.  Estimation of differential in vitro sensitivity of non-Hodgkin lymphomas to anticancer drugs.

Authors:  O Sanfilippo; M G Daidone; A Costa; R Canetta; R Silvestrini
Journal:  Eur J Cancer       Date:  1981-02       Impact factor: 9.162

4.  Distinction of macrophage subpopulations: measurement of functional cell parameters by flow cytometry.

Authors:  A Raffael; G Valet
Journal:  Adv Exp Med Biol       Date:  1982       Impact factor: 2.622

5.  "Cytomic" data system modules--modern electronic devices for flow cytometric data handling and presentation.

Authors:  V Kachel; K Schedler; H Schneider; L Haack
Journal:  Cytometry       Date:  1984-05

6.  Fast intracellular pH determination in single cells by flow-cytometry.

Authors:  G Valet; A Raffael; L Moroder; E Wünsch; G Ruhenstroth-Bauer
Journal:  Naturwissenschaften       Date:  1981-05

7.  Sensitive three-parameter flow-cytometric detection of abnormal cells in human cervical cancers: a pilot study.

Authors:  G Valet; M G Ormerod; H H Warnecke; G Benker; G Ruhenstroth-Bauer
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

8.  A new method for fast blood cell counting and partial differentiation by flow cytometry.

Authors:  G Valet
Journal:  Blut       Date:  1984-08

9.  Growth of human tumour cell colonies from biopsies using two soft-agar techniques.

Authors:  V D Courtenay; P J Selby; I E Smith; J Mills; M J Peckham
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

  9 in total
  2 in total

1.  Cytostatic drug testing in human leukemias by means of multiparametric flow cytometry.

Authors:  A Neubauer; H Sauer; G Valet
Journal:  Blut       Date:  1987-11

2.  NRAS mutant E132K identified in young-onset sporadic colorectal cancer and the canonical mutants G12D and Q61K affect distinct oncogenic phenotypes.

Authors:  Ryan Timothy D Yu; Reynaldo L Garcia
Journal:  Sci Rep       Date:  2020-07-03       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.